Results 201 to 210 of about 434,626 (386)

IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens [PDF]

, 2014
Tatsuo Miyamura, Tatsuo Kanda, Shingo Nakamoto, Makoto Arai, Masato Nakamura, Shuang Wu, Xia Jiang, Reina Sasaki, Yuki Haga, Shin Yasui, Yoshihiko Ooka, Tetsuhiro Chiba, Fumio Imazeki, Shigeru Mikami, Osamu Yokosuka   +14 more
openalex   +1 more source

The Global Burden of Leukemia, 1990–2021: A Systematic Analysis of Prevalence, DALYs, and Risk Factors From the Global Burden of Disease Study

Med Research, EarlyView.
Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu, Haini Zhang, Shuang Luo, Xiangmei Zhang, Mei Tan, Jinmei Chen, Pei Huang, Yan Chen, Zuochen Du   +8 more
wiley   +1 more source

Proliferative response of peripheral blood mononuclear cells to recombinant hepatitis C virus (HCV) antigens in patients with HCV infection.

, 1993
Tetsufumi Ito, Kazutaka KUROKOUCHI, Keiji Arima, Tsubasa MORITA, Mikio Nishioka   +4 more
openalex   +2 more sources

Incidence and Mortality Risks of Gastrointestinal Cancers During Working‐Age Period: Trends and Disparities in 204 Countries and Territories (1990–2021)

Med Research, EarlyView.
This comprehensive analysis of gastrointestinal (GI) cancer risk reveals that globally, one in 46 people will develop and one in 73 will die from GI cancers during working age (15–64 years), with 2021 incidence and mortality risks of 2.19% and 1.37%, respectively. Key findings demonstrate striking gender disparities, with males facing nearly double the
Yiming Song, Zhongge Ji, Xunbing Zhang, Qian Liang, Zeyu Li, Xiaojie Huang, Jinnan Chen, Yujie Zhou, Xinyuan Wang, Zhao Li, Liuyi Yang, Yixin Qian, Xiaolu Lin, Qingwei Zhang, Xiaobo Li   +14 more
wiley   +1 more source

Iron, HCV, and Liver Cancer: Hard Metal Setting the Pace? [PDF]

, 2006
Sebastian Mueller, Nezam H. Afdhal, Detlef Schuppan   +2 more
openalex   +1 more source

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

New England Journal of Medicine, 2017
E. Gane, E. Lawitz, D. Pugatch, G. Papatheodoridis, N. Bräu, A. Brown, S. Pol, V. Leroy, M. Persico, Christophe Moreno, M. Colombo, E. Yoshida, D. Nelson, Christine A. Collins, Y. Lei, M. Kosloski, F. Mensa   +16 more
semanticscholar   +1 more source

Human Cyclophilins—An Emerging Class of Drug Targets

Medicinal Research Reviews, EarlyView.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova, Hana Navratilova, Kamil Musilek, Ondrej Benek   +3 more
wiley   +1 more source

Clinical Characteristics and Outcomes in Patients with HCV NS5A Resistance and Significant Fibrosis: A Single Center Experience

, 2017
Ariel W. Aday, Khurram Mazhar, Marcus Kouma, Victoria Paschall, Jayma DeGroot, Rosamma Parangimalil, Geri Brown   +6 more
openalex   +1 more source

Establishment and Comparative Analysis of Radiation‐Induced Liver Disease in Normal and Fibrotic Rat Models

Precision Radiation Oncology, EarlyView.
This study successfully established two novel rat models of radiation‐induced liver disease (RILD), one in healthy livers and the other in TAA‐induced fibrotic livers, providing valuable insights into the combined effects of radiation and pre‐existing fibrosis.
Yanting Jiang, Yuxi Ding, Fang Wang, Danni Chen, Weixiang Zhong, Zhongjie Lu, Yixiang J. Wang, Senxiang Yan, Xiaoguang Liu, Feng Zhao   +9 more
wiley   +1 more source

Peer Interventions for Hepatitis C Testing and Treatment in OECD Countries: A Systematic Scoping Review. [PDF]

J Viral Hepat
Daly S, Reid L, Buchanan R, McCulloch P, Flowers P, Frankis J, Vojt G.   +6 more
europepmc   +1 more source